As analytics and Big Data continue being integrated into organizational methods from the C-suite to the front lines, Josh Angela and Sullivan Zutavern believe that a new kind of company will emerge. Zutavern and Sullivan don’t think the mature mathematical corporation exists yet, but they do have a privileged view of the forces that will produce it.
Both are professionals at Booz Allen Hamilton Inc., where Sullivan organized and leads the company’s data technology and advanced analytics capabilities, and Zutavern is developing applications of machine cleverness to organizational management and strategy. In their new book, The Mathematical Corporation, Sullivan, and Zutavern explore how company leaders can prepare for and accelerate the transformation to a new corporate model.
The pursuing excerpt from Chapter 7, edited for space, examines the unavoidable ethical conflicts that will arise – and also have already arisen – as the ability of companies to collect and parse personal data explodes. And more important, it points out the necessity to proactively anticipate those issues. Read the excerpt here.
- Global Ball Mill Market Forecast (2018-2023)
- Breakdown of internal management controls leading to faulty manufacturing processes
- Better understand the business business model (current and future)
- Author Identifiers in Scholarly Repositories, Simeon Warner. (pdf, 680K)
- Science Education (Secondary Chemistry) – M.A
- A recovery in the high-yield connection markets
- Excellent written, social and verbal communication
Getting an accurate nationwide count of medical patients is impossible because California, Washington and Maine don’t keep data. However, absent those continuing states year nearly 1 the AP found at the end of last.4 million individuals were active patients in a medical marijuana program. The AP quotes if those claims were added to the quantity would increase by about 1 million.
As more says legalize marijuana for all those adults, some who have been using it are sense disenfranchised medically. In Michigan, where medical marijuana has been legal for over ten years, the creation of a new licensing system for medical dispensaries has sparked court challenges as the state prepares for the advent of general marijuana sales later this season. A cancer tumor patient there submitted a Federal government lawsuit this month, alleging the slow licensing pace has generated a shortage of the products she needs to maintain her weight and control pain.
In Washington, medical patients feel these were pushed apart when that state merged its medical and general-use marketplaces, which is what’s occurring in California. Los Angeles dispensary owner Jerred Kiloh sells medical and recreational weed and said those marketplaces are quickly becoming one, since few companies are going to produce products for a vanishing group of customers.
He said his medical business has dipped to 7% of overall sales and it is dropping every month. Kiloh, leader of the LA trade group United Cannabis Business Association. In Oregon, regulators are desperate for a route that preserves the state’s trailblazing low-cost medical pot program while tamping down on a still-thriving dark market.
A special condition commission created to oversee the marketplace transition previously put out a report this year that found affordability and insufficient gain access to are major hurdles for Oregon’s patients. Anthony Taylor, a medical marijuana advocate who sits on the Oregon Cannabis Commission. General legalization has “indelibly transformed the medical market,” and regulators want to recognize the patients most affected by the changeover, said Steve Marks, executive director of the Oregon Liquor Control Commission, which oversees Oregon’s recreational marijuana program. Lawmakers just passed a bill that includes language that will allow the payment to explore a pilot program for home delivery of medical cannabis to patients in underserved areas, he said.